文献速递烧伤创面修复

四种门诊烧伤敷料治疗部分厚度烧伤的前瞻性随机对照试验

Treatment of Partial Thickness Burns: A Prospective, Randomized Controlled Trial Comparing Four Routinely Used Burns Dressings in an Ambulatory Care Setting.
PubMed 文献 · J Burn Care Res · 2021-01-01

该前瞻性随机对照试验比较了四种敷料用于成人部分厚度烧伤的再上皮化时间与成本效果。调整混杂因素后,Mepilex® Ag较Biobrane™再上皮化时间缩短(IRR:1.26;95% CI:1.07-1.48,P < .01),且成本效果优势概率较高。

要点

  • Mepilex® Ag较Biobrane™显著缩短再上皮化时间(IRR:1.26;95% CI:1.07-1.48,P < .01)。
  • Mepilex® Ag优于Biobrane™、Acticoat™、Aquacel® Ag的成本效果概率分别为99%、71%、53%。
  • 患者满意度与舒适度Biobrane™似更优,但未体现在愈合结局中。

核心结论

  • Mepilex® Ag在部分厚度烧伤中再上皮化更快且成本效果更好。
  • 患者满意度与舒适度Biobrane™似更优,但未反映在愈合结局中。
  • 敷料选择应结合患者教育、临床经验及产品可及性个体化决定。

研究设计与样本

  • 前瞻性随机对照试验,比较四种常规门诊烧伤敷料。
  • 随机分配至Biobrane™、Acticoat™、Mepilex® Ag或Aquacel® Ag组。

主要发现

  • 主要分析终点为>95%再上皮化。
  • 调整性别、年龄、吸烟状态、烧伤机制、TBSA及急救充分性后,Mepilex® Ag较Biobrane™再上皮化时间缩短(IRR:1.26;95% CI:1.07-1.48,P < .01)。
  • Mepilex® Ag优于Biobrane™、Acticoat™、Aquacel® Ag的成本效果概率分别为99%、71%、53%。

关键数值与推荐

  • 再上皮化时间比较采用IRR:1.26(95% CI:1.07-1.48,P < .01),对象为调整混杂因素后的Mepilex® Ag vs Biobrane™。
  • 成本效果优势概率:Mepilex® Ag vs Biobrane™为99%,vs Acticoat™为71%,vs Aquacel® Ag为53%。

临床怎么用

  • 部分厚度烧伤门诊治疗可优先考虑Mepilex® Ag以加速愈合并降低成本。
  • 需结合患者偏好(Biobrane™舒适度可能更佳)及产品可及性个体化选择敷料。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This prospective, randomized controlled trial study compared the effects of four dressings for adult partial thickness burns, focusing on re-epithelialization time and cost effectiveness. Adults with partial thickness burns meeting inclusion criteria were randomized to either Biobrane™, Acticoat™, Mepilex® Ag, or Aquacel® Ag. Primary endpoint for analysis was >95% re-epithelialization. Incremental cost-effectiveness ratios were calculated based on dressing costs. Dominance probabilities between treatment arms were calculated from bootstrap resampling trial data. One hunderd thirty-one partial thickness burn wounds in 119 patients were randomized. Adjusting for sex, age, smoking status, burn mechanism, TBSA, and first aid adequacy, Mepilex® Ag had a reduced time to re-epithelialization compared to Biobrane™ (IRR: 1.26; 95% CI: 1.07-1.48, P < .01). Economic analysis showed that there was a 99%, 71%, and 53% probability that Mepilex® Ag dominated (cheaper and more effective) Biobrane™, Acticoat™, and Aquacel® Ag, respectively. Mepilex® Ag achieved faster re-epithelialization and better cost effectiveness. Patient satisfaction and comfort seems better with Biobrane™ although not reflected within the end outcome of the healed wound. It is the patients' (after extensive education) and clinicians' choice, level of experience, and availability of products in praxis that will guide the decision as to which the product is used individually on which patient.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Aggarwala S, Harish V, Roberts S, et al. Treatment of Partial Thickness Burns: A Prospective, Randomized Controlled Trial Comparing Four Routinely Used Burns Dressings in an Ambulatory Care Setting. J Burn Care Res. 2021. PMID: 32930784. doi:10.1093/jbcr/iraa158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。